Lincomycin Oral Capsules/Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Capsules/Tablets
Available Strengths: 250mg, 500 mg
Reference Brands: Lincocin (US)
Category:
Antibiotics
Lincomycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing peptide elongation. It effectively treats severe Gram-positive infections, such as skin and soft tissue infections. Benefits include rapid bacterial eradication, high efficacy against resistant strains, and oral administration for outpatient care when used appropriately.
Lincomycin Oral Capsules/Tablets is available in Oral Capsules/Tablets
and strengths such as 250mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lincomycin Oral Capsules/Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lincomycin Oral Capsules/Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lincomycin capsules and tablets are approved in the EU and US for treating severe Gram-positive infections, including skin, soft tissue, and bone infections. In the EU, brands like Lincocin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval relies on extensive clinical data, with generic formulations available. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert support with regulatory dossiers, compliance, and registration, visit PharmaTradz. We ensure seamless market access for lincomycin formulations, adhering to European and US standards for safe, effective antibacterial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing